Second Affiliated Hospital Of Nanchang University
Clinical trials sponsored by Second Affiliated Hospital Of Nanchang University, explained in plain language.
-
New hope for lung cancer patients with tough brain spread
Disease control Recruiting nowThis study is testing a more intensive treatment for people with advanced lung cancer where the disease has spread to the lining of the brain and spine, and has gotten worse despite standard targeted therapy. About 30 participants will receive a higher dose of their targeted pill…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Tiny beads vs. pills: new approach for Hormone-Driven high blood pressure
Disease control Recruiting nowThis study is testing whether a minimally invasive procedure called superselective adrenal artery embolization works as well as or better than standard medication (spironolactone) for people with primary aldosteronism, a hormone condition causing hard-to-control high blood pressu…
Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New study pits popular Weight-Loss drug against strict diet for diabetes control
Disease control Recruiting nowThis study is comparing two approaches for people newly diagnosed with type 2 diabetes who also have excess liver fat. For 12 weeks, one group will receive weekly injections of the medication semaglutide, while the other will follow a strict calorie-restricted diet. Researchers w…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New Triple-Threat attack on tough lung cancer aims to enable surgery
Disease control Recruiting nowThis study is testing a three-part treatment for stage III non-small cell lung cancer that cannot initially be removed by surgery. The goal is to see if combining a specialized form of radiation (SFRT) with an immunotherapy drug (tislelizumab) and standard chemotherapy can shrink…
Phase: PHASE2, PHASE3 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Could a 'Poop Transplant' for your eyes cure dryness?
Disease control Recruiting nowThis early-stage study is testing whether transplanting healthy bacteria from a donor's eye to a patient's eye can help treat dry eye disease. It will involve 40 people with moderate to severe dry eye to see if this new approach reduces discomfort, improves tear production, and c…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Gut bacteria vs. blurry future: probiotic tested to halt Kids' myopia
Disease control Recruiting nowThis study is testing whether a probiotic supplement called MR-61 can help slow down the progression of nearsightedness (myopia) in children and teenagers. About 164 participants aged 3 to 18 will be randomly assigned to receive either the probiotic or a placebo for a period of t…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New shot aims to ease agony after shoulder surgery
Symptom relief Recruiting nowThis study is testing if adding a long-acting numbing medicine to a standard anti-inflammatory steroid shot during shoulder surgery helps patients recover better. About 70 adults having surgery for a torn rotator cuff and shoulder stiffness will be randomly assigned to get either…
Phase: NA • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Symptom relief
Last updated Apr 02, 2026 14:57 UTC